12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock rose 9.8% to $1.56 during Tuesday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) shares increased by 26.6% to $3.33 during Monday’s pre-market session. The company’s market cap…
Compass Therapeutics To Be Added To The Russell 2000 And Russell 3000 Indexes, Effective After The U.S. Market Opens On June 26, 2023
Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that it will be
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Avinger (NASDAQ:AVGR) shares moved upwards by 27.8% to $0.72 during Wednesday’s pre-market session. The market value of…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 25.3% to $1.93 during Friday’s pre-market session. The company’s market…
Jefferies Initiates Coverage On Compass Therapeutics with Buy Rating, Announces Price Target of $8
Jefferies analyst Maury Raycroft initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Buy rating and announces Price Target of $8.
Expert Ratings for Compass Therapeutics
Compass Therapeutics (NASDAQ:CMPX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Stifel Initiates Coverage On Compass Therapeutics with Buy Rating, Announces Price Target of $9
Stifel analyst Stephen Willey initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Buy rating and announces Price Target of $9.
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell 0.11% to 11,352.46. The S&P 500 also fell, dropping, 0.30% to 4,007.66.